■在北非,喉癌仍然是主要的男性病理学。在许多国家,男女之间的差距正在缩小。这项研究旨在检查流行病学,临床,治疗性的,并对23例女性喉癌患者进行了随访。
卡萨布兰卡8月20日医院头颈外科23例原发性喉癌患者的病历,2012年1月至2016年9月,进行了回顾。人口统计,临床,内窥镜,放射学,外科,并收集随访数据。
■所有接受LC治疗的患者中有7%是女性,受影响最大的年龄组是60至79岁(52%),52%无主要危险因素,所有患者都有表皮样癌,48%的患者有T2肿瘤。T1、T3和T4a分别为17%,22%,和13%。43%的病例中出现N1(n=10),35%(n=8),N2b占17%(n=4),4%的N2c(n=1)。所有患者均为M0。这一系列的患者都接受了手术治疗。在5年,生存率为83%。
■由于已发表研究中女性的比例有限,关于喉癌的性别差异仍有许多争议。因此,进一步的研究应寻求对女性喉癌的相关因素有更清晰的认识,以采取更适当的预防和早期诊断措施。
UNASSIGNED: In north Africa, laryngeal carcinomas remain a predominately male pathology. While in many countries the gap between men and women is narrowing. This study aimed to examine the epidemiological, clinical, therapeutic, and follow up data of a
case series of 23 female patients treated for laryngeal carcinoma.
UNASSIGNED: Medical records of a
case series of 23 patients for primary carcinoma of the larynx at the Department of Head and Neck Surgery of the 20 August Hospital of Casablanca, between January 2012 and September 2016, were reviewed. Demographic, clinical, endoscopic, radiological, surgical, and follow-up data were collected.
UNASSIGNED: 7% of all the patients treated for LC were women, The most affected age group was between 60 and 79 years (52%), 52% had no major risk factor, all patients had an epidermoid carcinoma, 48% of patients had T2 tumors. T1, T3, and T4a were found in respectively 17%, 22%, and 13%. N1 in 43% of the cases (n = 10), N0 in 35% (n = 8), N2b in 17% (n = 4), N2c in 4% (n = 1). All patients were M0. All the patients in this series have undergone surgical treatment. At 5 years, the survival rate was 83%.
UNASSIGNED: Since the proportions of women in published studies are limited, there are still many controversies about gender differences in laryngeal cancer. Therefore, further studies should seek a clearer understanding of factors involved in female laryngeal cancer to adopt more appropriately the measures of prevention and early diagnosis.